| Exocrine pancreatic insufficiency
Creon vs Pancreaze
Side-by-side clinical, coverage, and cost comparison for exocrine pancreatic insufficiency.Deep comparison between: Creon vs Pancreaze with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsPancreaze has a higher rate of injection site reactions vs Creon based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Pancreaze but not Creon, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Creon
Pancreaze
At A Glance
Oral
With each meal and snack
Pancreatic enzyme replacement
Oral
With meals and snacks
Pancreatic enzyme replacement
Indications
- Exocrine pancreatic insufficiency
- Exocrine pancreatic insufficiency
Dosing
Exocrine pancreatic insufficiency (adults and pediatric >= 4 years) Initial 500 lipase units/kg/meal orally; titrate up to 2,500 lipase units/kg/meal or 10,000 lipase units/kg/day; administer half-dose with each snack.
Exocrine pancreatic insufficiency (adults, chronic pancreatitis or pancreatectomy) Initial 500 to 1,000 lipase units/kg/meal orally; titrate up to 2,500 lipase units/kg/meal or 10,000 lipase units/kg/day.
Exocrine pancreatic insufficiency (pediatric > 12 months to < 4 years) Initial 1,000 lipase units/kg/meal orally; titrate up to 2,500 lipase units/kg/meal or 10,000 lipase units/kg/day.
Exocrine pancreatic insufficiency (birth to 12 months) 3,000 lipase units per 120 mL of formula or per breastfeeding, orally.
Exocrine pancreatic insufficiency, adults and pediatric >= 4 years 500 lipase units/kg/meal orally, titrated up to 2,500 units/kg/meal or 10,000 units/kg/day; do not exceed 4,000 units/g fat/day.
Exocrine pancreatic insufficiency, pediatric >12 months to <4 years 1,000 lipase units/kg/meal orally, titrated up to 2,500 units/kg/meal or 10,000 units/kg/day; do not exceed 4,000 units/g fat/day.
Exocrine pancreatic insufficiency, birth to 12 months 2,600 lipase units (one capsule) per 120 mL of formula or per breastfeeding, administered orally.
Contraindications
—
—
Adverse Reactions
Most common (>=4%) Vomiting, dizziness, cough, hyperglycemia, hypoglycemia, abdominal pain, abnormal feces, flatulence, frequent bowel movements, nasopharyngitis, irritability, decreased appetite.
Postmarketing Blurred vision, fibrosing colonopathy, distal intestinal obstruction syndrome, abdominal pain, diarrhea, flatulence, constipation, nausea, anaphylaxis, asthma, hives, pruritus, myalgia, muscle spasm, urticaria, rash.
Most common diarrhea, vomiting
Serious fibrosing colonopathy, irritation of oral mucosa, hyperuricemia, risk of viral transmission, hypersensitivity reactions
Postmarketing blurred vision, fibrosing colonopathy, distal intestinal obstruction syndrome, abdominal pain, flatulence, constipation, nausea, anaphylaxis, asthma, hives, pruritus, asymptomatic elevations of liver enzymes, myalgia, muscle spasm, urticaria, rash
Pharmacology
Pancreatic enzyme replacement; contains lipases, proteases, and amylases that catalyze hydrolysis of fats, proteins, and starches in the duodenum and proximal small intestine, acting like digestive enzymes physiologically secreted by the pancreas.
Pancrelipase is a porcine-derived pancreatic enzyme product containing lipases, proteases, and amylases that catalyze hydrolysis of fats, proteins, and starches in the duodenum and proximal small intestine, replacing digestive enzymes deficient in exocrine pancreatic insufficiency.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Creon
- Covered on 5 commercial plans
- PA (4/12) · Step Therapy (4/12) · Qty limit (9/12)
Pancreaze
- Covered on 5 commercial plans
- PA (6/12) · Step Therapy (10/12) · Qty limit (9/12)
UnitedHealthcare
Creon
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Pancreaze
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (5/8) · Qty limit (0/8)
Humana
Creon
- Covered on 0 commercial plans
- PA (0/3) · Step Therapy (0/3) · Qty limit (0/3)
Pancreaze
- Covered on 0 commercial plans
- PA (0/3) · Step Therapy (2/3) · Qty limit (0/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
$5/fillfill
Creon On Course Co-pay CardCommercial or private insurance
Medicare, Medicaid, VA, TRICARE
Cost estimate not availableAssistance Fund: Cystic Fibrosis
Commercial or private insurance
Medicare, Medicaid, VA, TRICARE
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
PancreazeView full Pancreaze profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.